Clinical Study Results
What kind of study was this?
This was an “open-label” study. This means the researchers and the participant knew
what the participant was taking.
The doses were measured in milligrams, also known as mg. The doses of each
substance and study treatment were:
• 200 mg of caffeine as a tablet
• 20 mg of omeprazole as a tablet
• 2 mg of midazolam as a syrup
• 225 mg of adavosertib as 3 tablets
The study was done in 2 Parts. In Part A there were 2 treatment periods. The
participants took 2 doses of caffeine, omeprazole, and midazolam and 5 doses of
adavosertib.
In Part B the participants took 5 doses of adavosertib.
The charts below show the treatments in each part.
Part A
Treatment Period 1 Treatment Period 2
Days 1 1 2 3
Caffeine, omeprazole, midazolam  
Adavosertib in the morning   
Adavosertib at night  
Part B
Days 1 2 3 4 5
Adavosertib in the morning   
Adavosertib at night  
3